RNAi therapy mitigates preeclampsia symptoms in UMass Medical School study
A new study by Anastasia Khvorova, PhD, and Melissa Moore, PhD, at UMass Medical School and colleagues at Beth Israel Deaconess Medical Center and Western Sydney University, suggests that RNA interference therapy could be a potential strategy for the treatment of preeclampsia.
Read moreStay Connected
Welcome Video from Chancellor Collins
"Throughout the world and close to home we are UMass; dignified and determined; principled and purposeful; respected and relied upon!"
